The rising incidence of infectious diseases is creating an urgent need for efficient diagnostics, which is driving growth in the global market for cell and tissue analysis (CTA) market. BCC Research reveals in its new report that another key market driver, the use of tissue and cells in life sciences research and molecular diagnostics, is creating big demand for upstream isolation and downstream analytical products.
Cell and tissue analysis involves the study of the functional and structural aspects of the cell and tissue. The major technologies used in cell and tissue analysis are microarrays, high-throughput screening, flow cytometers, antibody and cell-based assays, providing high efficiency and accuracy in bioresearch.
The global cell and tissue analysis market reached $10.8 billion in 2015 and should reach nearly $12.5 billion by 2020, reflecting a compound annual growth rate (CAGR) of 2.8% through 2020. Cell separation and cell and tissue characterization products dominated the global market. The North American market, the major consumer, reached nearly $4.5 billion in 2015 and should reach more than $5.5 billion by 2020, with a CAGR of 4.2%. Emerging markets reached $3.2 billion in 2015 and should reach nearly $3.6 billion by 2020, with a CAGR of 2%.
With the increase in focus on molecular diagnostics, the advancement in CTA techniques has reached new arenas. Extensive research in the field has led to the development of efficient, user friendly and affordable products. Research and development spending, along with increasing competition, patent expiries and new technologies are giving a new direction to the market. The advancements, new product launches and changing lifestyles are influencing market growth.
“The detailed analysis of cells helps to understand the mechanism behind the cellular pathways for developing better therapies and accurate diagnosis,” says BCC Research analyst Shalini S. Dewan. “Technological advances in cellular engineering now have the ability to produce customized products for specific research and industrial applications. The cell remains at the centre of experimental design in academic research. Socioeconomic development has made a healthy lifestyle more accessible, as well. The necessity of a healthy and safe world has also led to the increased demand for cell and tissue analysis products.”
Global Markets And Technologies For Cell And Tissue Analysis (BIO068C) analyses CTA products, including commercialized products used in the isolation, purification and analysis of cells, as well as novel products and technologies that soon may be commercially viable. Analyses of global market drivers and trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020 also are provided.